(2020) Benign prostatic hyperplasia treatment using plasmonic nanoparticles irradiated by laser in a rat model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. p. 110118. ISSN 1950-6007
Full text not available from this repository.
Abstract
OBJECTIVE In the current study we have stimulated the efficacy of plasmonic nanoparticles (NPs) by laser hyperthermia to achieve a less invasive method for tumor photothermal therapy of benign prostatic hyperplasia (BPH). METHODS The levels of apoptosis on induced BPH in rats were assessed after treatment and revealed and recorded by various assayed. Moreover, the expression of caspases was considered to demonstrate the apoptotic pathways due to laser induced plasmonic NPs. RESULTS In the Laser + NPs group prostate size of induced BPH decreased. Laser + NPs also decreased prostate specific antigen in comparison with the BPH groups. Furthermore, Laser + NPs attenuated BPH histopathologic indices in the rats. Laser + NPs induced apoptosis in prostatic epithelial cells via caspase-1 pathway. CONCLUSIONS Altogether, the approach and findings from this study can be applied to introduce the laser irritated NPs method as a novel and less invasive therapy for patients suffering from BPH.
Item Type: | Article |
---|---|
Page Range: | p. 110118 |
Journal or Publication Title: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |
Volume: | 127 |
ISSN: | 1950-6007 |
Depositing User: | ms soheila Bazm |
URI: | http://eprints.ssu.ac.ir/id/eprint/11358 |
Actions (login required)
View Item |